Dow Down 1.83% Nasdaq Down 2.26%

Dynavax Technologies Corporation (DVAX)

-NasdaqCM
19.86 Down 1.19(5.65%) 10:49AM EST - Nasdaq Real Time Price
Prev Close:21.05
Open:20.39
Bid:19.80 x 400
Ask:19.93 x 100
1y Target Est:47.00
Beta:1.26776
Earnings Date:Mar 3 - Mar 7 (Est.)
Day's Range:19.42 - 20.55
52wk Range:15.84 - 32.49
Volume:294,096
Avg Vol (3m):975,138
Market Cap:763.12M
P/E (ttm):N/A
EPS (ttm):-3.27
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Headlines

» More Headlines for DVAX

Comparison

Symbol% ChgMkt Cap
DVAXDown 5.65%763.12M
GSKDown 2.89%95.78B
MRKDown 1.50%135.88B

Key Statistics

Forward P/E (1 yr):N/A
P/S (ttm):143.36
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-15) :-3.29
Quarterly EPS Est (Dec-15) :-0.75
Mean Recommendation*:1.8
PEG Ratio (5 yr expected):N/A

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Dynavax Technologies Corporation, a clinical-stage biopharmaceutical company, discovers and develops novel vaccines and therapeutics in the United States. View More
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback